Clinical development of the novel oncolytic coxsackievirus B3 targeting malignant tumors
Clinical development of the novel oncolytic coxsackievirus B3 targeting malignant tumors
批准号:
23240133
负责人:
TANI Kenzaburo
金额:
$31.45万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011-04-01 至 2015-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Differential susceptibility of cancer stem cells and cancer cells undergoing epithelial-mesenchymal transition to oncolysis by CVB3 infection.
癌症干细胞和通过 CVB3 感染进行上皮间质转化至溶瘤的癌细胞的不同易感性。
DOI:
--
发表时间:
2013
期刊:
影响因子:
--
作者:
[Miyako Sagara, Hiroyuki Inoue, Shohei Miyamoto, Chika Sakamoto, Yuki Nakano, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi, Kenzaburo Tani]
通讯作者:
Kenzaburo Tani
肺癌幹細胞を標的とした新規遺伝子改変麻疹腫瘍溶解性ウイルス療法
针对肺癌干细胞的新型转基因麻疹溶瘤病毒疗法
DOI:
--
发表时间:
2013
期刊:
影响因子:
--
作者:
[Hiroyuki Inoue, Keisuke Yasunari, Yumiko Matsumura, Kaname Nosaki, Shohei Miyamoto, Koichi Takayama, Yoichi Nakanishi, and Kenzaburo Tani]
通讯作者:
and Kenzaburo Tani
医薬組成物
药物组合物
DOI:
--
发表时间:
2019
期刊:
影响因子:
--
作者:
[]
通讯作者:
MicroRNA-regulated coxsackievirus B3 abrogates its pathogenicity retaining oncolytic activity.
MicroRNA 调节的柯萨奇病毒 B3 消除了其致病性,保留了溶瘤活性。
DOI:
--
发表时间:
2013
期刊:
影响因子:
--
作者:
[Shohei Miyamoto, Hiroyuki Inoue, Miyako Sagara, Beibei Wang, Koichi Takayama, Hiroyuki Shimizu, Yoichi Nakanishi, Kenzaburo Tani]
通讯作者:
Kenzaburo Tani
Infection with Echovirus 4 elicits potent oncolytic activity against cisplatin-resistant esophageal carcinoma.
Echovirus 4 感染可引发针对顺铂耐药食管癌的强效溶瘤活性。
DOI:
--
发表时间:
2013
期刊:
影响因子:
--
作者:
[Hiroyuki Inoue, Keisuke Yasunari, Beibei Wang, Shohei Miyamoto, Koichi Takayama, Yoichi Nakanishi, Kenzaburo Tani]
通讯作者:
Kenzaburo Tani
共 17 条
Development of evolutional gene modified T cell transfusion therapy using novel and self-developed measles viral vector
-
批准号:17H01547
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$26.87万
-
财政年份:2017
-
负责人:TANI Kenzaburo
-
依托单位:
Construction of the system for hematopoietic cell production from human ES cells and the analysis of its molecular basis toward the development of ES cell therapies
-
批准号:20390273
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.06万
-
财政年份:2008
-
负责人:TANI Kenzaburo
-
依托单位:
Development of new gene therapy vectors and the preclinical cancer animal model system using common marmoset
-
批准号:17016053
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$32.0万
-
财政年份:2005
-
负责人:TANI Kenzaburo
-
依托单位:
Development of efficient hematopoietic stem cell proliferation systems using our own established ES cells of small monkey, common marmoset
-
批准号:17390279
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.86万
-
财政年份:2005
-
负责人:TANI Kenzaburo
-
依托单位:
Elucidation of pathogenic genes for abnormal hematopoiesis and the development of gene therapy in paroxysmal nocturnal hemoglobinuria
-
批准号:14370299
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.96万
-
财政年份:2002
-
负责人:TANI Kenzaburo
-
依托单位:
Basic study towords reconstitution of normal and leukemic human hemopoiesis in small monkey of common marmoset
-
批准号:11557073
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.64万
-
财政年份:1999
-
负责人:TANI Kenzaburo
-
依托单位:
Development of new immunogene therapy for refractory leukemia and lymphoma
-
批准号:10470208
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.26万
-
财政年份:1998
-
负责人:TANI Kenzaburo
-
依托单位: